chr3-165773492-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000055.4(BCHE):c.1699G>A(p.Ala567Thr) variant causes a missense change. The variant allele was found at a frequency of 0.194 in 1,602,676 control chromosomes in the GnomAD database, including 31,008 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.18 ( 2527 hom., cov: 33)
Exomes 𝑓: 0.20 ( 28481 hom. )
Consequence
BCHE
NM_000055.4 missense
NM_000055.4 missense
Scores
3
15
Clinical Significance
Conservation
PhyloP100: 4.44
Genes affected
BCHE (HGNC:983): (butyrylcholinesterase) This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0018072128).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.195 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCHE | NM_000055.4 | c.1699G>A | p.Ala567Thr | missense_variant | 4/4 | ENST00000264381.8 | NP_000046.1 | |
BCHE | NR_137635.2 | n.292G>A | non_coding_transcript_exon_variant | 3/3 | ||||
BCHE | NR_137636.2 | n.1896G>A | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCHE | ENST00000264381.8 | c.1699G>A | p.Ala567Thr | missense_variant | 4/4 | 1 | NM_000055.4 | ENSP00000264381.3 |
Frequencies
GnomAD3 genomes AF: 0.183 AC: 27788AN: 151916Hom.: 2526 Cov.: 33
GnomAD3 genomes
AF:
AC:
27788
AN:
151916
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.176 AC: 43392AN: 246726Hom.: 4056 AF XY: 0.180 AC XY: 23963AN XY: 133496
GnomAD3 exomes
AF:
AC:
43392
AN:
246726
Hom.:
AF XY:
AC XY:
23963
AN XY:
133496
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.195 AC: 283194AN: 1450642Hom.: 28481 Cov.: 31 AF XY: 0.195 AC XY: 140753AN XY: 722172
GnomAD4 exome
AF:
AC:
283194
AN:
1450642
Hom.:
Cov.:
31
AF XY:
AC XY:
140753
AN XY:
722172
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.183 AC: 27789AN: 152034Hom.: 2527 Cov.: 33 AF XY: 0.181 AC XY: 13446AN XY: 74326
GnomAD4 genome
AF:
AC:
27789
AN:
152034
Hom.:
Cov.:
33
AF XY:
AC XY:
13446
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
763
ALSPAC
AF:
AC:
767
ESP6500AA
AF:
AC:
835
ESP6500EA
AF:
AC:
1735
ExAC
AF:
AC:
21914
Asia WGS
AF:
AC:
496
AN:
3468
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 03, 2021 | See Variant Classification Assertion Criteria. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 15, 2023 | Variant summary: BCHE c.1699G>A (p.Ala567Thr) results in a non-conservative amino acid change in the encoded protein sequence. Two of three in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.18 in 246726 control chromosomes in the gnomAD database, including 4056 homozygotes. The observed variant frequency is approximately 11.12 fold of the estimated maximal expected allele frequency for a pathogenic variant in BCHE causing Deficiency Of Butyrylcholine Esterase phenotype (0.016), indicating the variant is benign. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Two submitters classified the variant as benign while one classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as benign. - |
Deficiency of butyrylcholinesterase Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Butyrylcholinesterase activity Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Jul 21, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at